Clinical Trials Browser

Phase 1/2 × INDUSTRY × carotuximab × Clear all

NCT01806064 2020-10-19

Randomized Phase 2 Trial of Axitinib and TRC105 Versus Axitinib Alone in Patients Renal Cell Carcinoma

Phase 1/2 Terminated

173 enrolled 17 charts

Carcinoma, Renal Cell

NCT02560779 2020-07-17

Trial of TRC105 and Sorafenib in Patients With HCC

Phase 1/2 Completed

27 enrolled 11 charts

Gastrointestinal

Carcinoma, Hepatocellular

NCT01975519 2020-05-20

A Phase 1B Dose-escalation and Phase 2a Study of Carotuximab (TRC105) in Combination With Pazopanib in Patients With Advanced Soft Tissue Sarcoma

Phase 1/2 Completed

111 enrolled 15 charts

Hemangiosarcoma, Sarcoma

NCT01326481 2019-03-18

TRC105

Phase 1/2 Completed

19 enrolled 9 charts

Breast Neoplasms